Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies

Aprea Therapeutics · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
gastric-cancernon-small-cell-lung-cancernsclcpembrolizumab
bladder cancer, gastric cancer, non small cell lung cancer, nsclc, urothelial carcinoma, advanced solid tumor, pembrolizumab, apr-246, aprea, eprenetapopt, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 906150
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.